开盘$8.17
昨收$8.01
当日区间$7.88 – $8.69
成交量9.27M
市值$9.15B
市盈率（TTM）–
股息率–
IBRX 相关新闻
匹配 ImmunityBio 或代码 IBRX 的头条新闻，按最新排序。
- Piper Sandler Maintains ImmunityBio(IBRX.US) With Buy Rating, Maintains Target Price $12
- H.C. Wainwright Maintains ImmunityBio(IBRX.US) With Buy Rating, Maintains Target Price $15
- BTIG Maintains ImmunityBio(IBRX.US) With Buy Rating, Maintains Target Price $12
- Earnings Flash (IBRX) ImmunityBio Posts Q2 Net Loss $0.22 a Share, Vs. FactSet Est of $0.08 Loss 负面
- BTIG Maintains ImmunityBio(IBRX.US) With Buy Rating, Cuts Target Price to $12 负面
- ImmunityBio (IBRX) Receives a Buy From H.C. Wainwright
- H.C. Wainwright Sticks to Its Buy Rating for ImmunityBio (IBRX)
- Piper Sandler Maintains ImmunityBio(IBRX.US) With Buy Rating, Raises Target Price to $12 正面
- BTIG Maintains ImmunityBio(IBRX.US) With Buy Rating, Maintains Target Price $13
- BTIG Maintains ImmunityBio(IBRX.US) With Buy Rating, Raises Target Price to $13 正面
- BTIG Maintains ImmunityBio(IBRX.US) With Buy Rating, Maintains Target Price $9
- H.C. Wainwright Maintains ImmunityBio(IBRX.US) With Buy Rating, Raises Target Price to $15 正面
- H.C. Wainwright Maintains ImmunityBio(IBRX.US) With Buy Rating, Maintains Target Price $10
- Form 144 | ImmunityBio(IBRX.US) Officer Proposes to Sell 7.66 Million in Common Stocks
- BTIG Maintains ImmunityBio(IBRX.US) With Buy Rating, Maintains Target Price $12
暂无评论——快来第一个聊聊 IBRX。